Specifically in ovarian cancer, although with some controversy [44,45], several reports already associated high GSH levels or glutathione S-transferase P1 (GSTP1) activity with cisplatin or carboplatin resistance [46,47,48,49,50,51,52,53]. This evidence concerns the gene GSTP1 and ovarian carcinoma.